Sotera Health (SHC) Stock Price, News & Analysis

Company Overview

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Key Stats

• Today's Range: $15.43 to $15.68
• 50-Day Range: $14.75 to $16.91
• 52-Week Range: $10.71 to $17.44
• Volume: 812,644 shs
• Average Volume: 1.32 million shs
• Market Capitalization: $4.39 billion
• P/E Ratio: 110.71
• Dividend Yield: N/A
• Price Target: $15.70
• Consensus Rating: Moderate Buy

Sotera Health Stock Analysis - MarketRank™

Sotera Health scored higher than 57% of companies evaluated by MarketBeat, and ranked 458th out of 1,001 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Sotera Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Sotera Health has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 18.75%

Earnings Growth

Earnings for Sotera Health are expected to grow by 18.75% in the coming year, from $0.64 to $0.76 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Sotera Health is 110.71, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.98.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sotera Health is 110.71, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 143.06.

Price to Book Value per Share Ratio

Sotera Health has a P/B Ratio of 9.87. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.70% of the float of Sotera Health has been sold short.

Short Interest Ratio / Days to Cover

Sotera Health has a short interest ratio ("days to cover") of 9.1.

Change versus previous month

Short interest in Sotera Health has recently decreased by 1.93%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Sotera Health does not currently pay a dividend.

Dividend Growth

Sotera Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

7.70% of the float of Sotera Health has been sold short.

Short Interest Ratio / Days to Cover

Sotera Health has a short interest ratio ("days to cover") of 9.1.

Change versus previous month

Short interest in Sotera Health has recently decreased by 1.93%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.67

News Sentiment

Sotera Health has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Sotera Health this week, compared to 3 articles on an average week.

Search Interest

Only 3 people have searched for SHC on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added Sotera Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Sotera Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $150,300,000.00 in company stock.

Percentage Held by Insiders

55.12% of the stock of Sotera Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

91.03% of the stock of Sotera Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SHC Stock Analysis - Frequently Asked Questions

How have SHC shares performed this year?

Sotera Health's stock was trading at $16.85 on January 1st, 2024. Since then, SHC shares have decreased by 8.0% and is now trading at $15.50.
View the best growth stocks for 2024 here.

How were Sotera Health's earnings last quarter?

Sotera Health (NASDAQ:SHC) issued its earnings results on Monday, August, 5th. The company reported $0.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.15 by $0.04. The firm's quarterly revenue was up 8.6% compared to the same quarter last year.

When did Sotera Health IPO?

Sotera Health (SHC) raised $1 billion in an initial public offering on Friday, November 20th 2020. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Credit Suisse, Goldman Sachs, Jefferies, Barclays, Citigroup and RBC Capital Markets acted as the underwriters for the IPO and BNP Paribas, Keybanc Capital Markets, Citizens Capital Markets and ING were co-managers.

Who are Sotera Health's major shareholders?

Sotera Health's top institutional investors include CWM LLC (0.02%), Louisiana State Employees Retirement System (0.01%), Handelsbanken Fonder AB (0.01%) and Creative Planning (0.01%). Insiders that own company stock include Pincus & Co Warburg, Gtcr Investment Xi Llc and Michael P Rutz.
View institutional ownership trends.

How do I buy shares of Sotera Health?

Shares of SHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Sotera Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sotera Health investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Alphabet (GOOG) and Walmart (WMT).

Company Calendar

• Last Earnings: 8/05/2024
• Today: 10/24/2024
• Next Earnings (Confirmed): 11/05/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Miscellaneous health & allied services, not elsewhere classified
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:SHC
• CUSIP: N/A
• CIK: 1822479
• Web: www.soterahealth.com
• Phone: 440-262-1410
• Fax: N/A
• Employees: 3,000
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $15.70
• High Stock Price Target: $17.00
• Low Stock Price Target: $13.00
• Potential Upside/Downside: +1.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 6 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.19
• Trailing P/E Ratio: 110.71
• Forward P/E Ratio: 24.22
• P/E Growth: N/A
• Net Income: $51.38 million
• Net Margins: 3.65%
• Pretax Margin: 8.40%
• Return on Equity: 47.26%
• Return on Assets: 6.44%

Debt

• Debt-to-Equity Ratio: 5.46
• Current Ratio: 2.93
• Quick Ratio: 2.59

Sales & Book Value

• Annual Sales: $1.10 billion
• Price / Sales: 4.00
• Cash Flow: $1.27 per share
• Price / Cash Flow: 12.16
• Book Value: $1.57 per share
• Price / Book: 9.87

Miscellaneous

• Outstanding Shares: 283,071,000
• Free Float: 127,106,000
• Market Cap: $4.39 billion
• Optionable: Optionable
• Beta: 2.07